chitosan has been researched along with Cystic Fibrosis of Pancreas in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Boková, S; Kašparová, P; Lokočová, K; Masák, J; Maťátková, O; Michailidu, J; Paldrychová, M; Rollová, M; Vaňková, E | 1 |
| Hill, DB; Rouillard, KR; Schoenfisch, MH | 1 |
| Agrawal, AK; Anjum, MM; Gade, S; Pandey, N; Patel, KK; Singh, S; Tilak, R; Tripathi, M | 1 |
| Al Jamal, KT; Alpar, O; Awad, G; El-Shamy, AE; Kan, PL; Mortada, N; Osman, R | 1 |
| Bader, RA; Wardwell, PR | 1 |
| Abdelghany, SM; Deacon, J; Donnelly, RF; Elborn, JS; Gilmore, BF; Jones, DS; Kissenpfennig, A; Megaw, J; Quinn, DJ; Schmid, D; Scott, CJ; Taggart, CC | 1 |
| Cardoso, O; Gaspar, MC; Murtinho, D; Olivier, JC; Pais, AA; Serra, ME; Sousa, JJ; Tewes, F | 1 |
| Fernández Fernández, E; Goycoolea, FM; Santos-Carballal, B; Weber, WM | 1 |
| Dragomir, A; Hjelte, L; Nydert, P | 1 |
9 other study(ies) available for chitosan and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Addition time plays a major role in the inhibitory effect of chitosan on the production of Pseudomonas aeruginosa virulence factors.
Topics: Anti-Bacterial Agents; Biofilms; Chitosan; Cystic Fibrosis; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Virulence Factors | 2022 |
Antibiofilm and mucolytic action of nitric oxide delivered via gas or macromolecular donor using in vitro and ex vivo models.
Topics: Administration, Inhalation; Animals; Biofilms; Chitosan; Cystic Fibrosis; Humans; In Vitro Techniques; Mucus; Nitric Oxide; Pseudomonas aeruginosa; Sputum; Swine | 2020 |
Alginate lyase immobilized chitosan nanoparticles of ciprofloxacin for the improved antimicrobial activity against the biofilm associated mucoid P. aeruginosa infection in cystic fibrosis.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Chitosan; Ciprofloxacin; Cystic Fibrosis; Drug Liberation; Enzymes, Immobilized; Erythrocytes; Hemolysis; Humans; Lung; Male; Nanoparticles; Platelet Aggregation; Polysaccharide-Lyases; Pseudomonas aeruginosa; Pseudomonas Infections; Rats, Wistar | 2019 |
Inhalable DNase I microparticles engineered with biologically active excipients.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Aerosols; Animals; Chitosan; Cystic Fibrosis; Delayed-Action Preparations; Deoxyribonuclease I; Dextrans; Drug Carriers; Drug Delivery Systems; Epithelial Cells; Excipients; Lactic Acid; Macrophages; Mice; Mucus; Ovalbumin; Polyglutamic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Powders; Viscosity | 2013 |
Immunomodulation of cystic fibrosis epithelial cells via NF-κB decoy oligonucleotide-coated polysaccharide nanoparticles.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Chitosan; Coated Materials, Biocompatible; Cystic Fibrosis; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Genes, Reporter; Humans; Immunomodulation; Interleukin-6; Interleukin-8; Luciferases; Nanoparticles; NF-kappa B; Oligodeoxyribonucleotides; Polysaccharides; Rats; Sialic Acids; Signal Transduction | 2015 |
Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).
Topics: Adult; Alginates; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Chitosan; Cystic Fibrosis; Deoxyribonuclease I; DNA; Glucuronic Acid; Hexuronic Acids; Humans; Microbial Sensitivity Tests; Nanoparticles; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Sputum; Tobramycin; Treatment Outcome | 2015 |
Optimization of levofloxacin-loaded crosslinked chitosan microspheres for inhaled aerosol therapy.
Topics: Anti-Bacterial Agents; Chitosan; Cross-Linking Reagents; Cystic Fibrosis; Drug Carriers; Drug Liberation; Humans; Levofloxacin; Microspheres; Particle Size; Powder Diffraction; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Therapy; Spectroscopy, Fourier Transform Infrared; Surface Properties; Technology, Pharmaceutical | 2015 |
Chitosan as a non-viral co-transfection system in a cystic fibrosis cell line.
Topics: Cell Line; Chitosan; Cystic Fibrosis; Green Fluorescent Proteins; Humans; Plasmids; RNA, Small Interfering; Transfection | 2016 |
Chitosan as a carrier for non-viral gene transfer in a cystic-fibrosis cell line.
Topics: Bronchi; Cell Line; Cell Survival; Chitosan; Cystic Fibrosis; Gene Transfer Techniques; Genetic Therapy; Green Fluorescent Proteins; Humans; Kidney; Luciferases; Polyethyleneimine | 2008 |